ESC Premium Access

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Congress Presentation

About the speaker

Doctor Jarl Emanuel Strange

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
1 follower

5 more presentations in this session

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Speaker: Doctor R. Amiya (Osaka, JP)


Characterization of major and clinically relevant non-major bleeding in the APEX trial

Speaker: Miss M. Yee (Boston, US)


Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)


Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)


Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Speaker: Professor H. Jeong (Iksan, KR)


Access the full session

Oral anticoagulants : news from large trials and registries

Speakers: Doctor J. Strange, Doctor R. Amiya, Miss M. Yee, Doctor M. Lamberts, Doctor M. Proietti...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb